Behavior Therapy for Tic Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how Comprehensive Behavioral Intervention for Tics (CBIT) can help people with chronic tics, which are sudden, repetitive movements or sounds. CBIT teaches individuals to control their tics by using a different, deliberate action instead. The trial seeks participants aged 12-21 who have experienced motor or vocal tics for at least a year. By video recording sessions and tracking changes over time, researchers hope to better understand the factors that enhance CBIT's effectiveness. As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could improve treatment strategies for chronic tics.
Will I have to stop taking my current medications?
The trial requires that participants not be on neuroleptic or antipsychotic medications. If you are taking other medications, they must be stable (same medication and dose) for at least 6 weeks with no planned changes during the study.
What prior data suggests that CBIT is safe for treating tic disorders?
Research has shown that CBIT (Comprehensive Behavioral Intervention for Tics) is a well-accepted treatment for tic disorders. It avoids medication, thereby sidestepping drug-related side effects. CBIT teaches patients to control their tics by learning a new action to prevent a tic.
Studies have found that CBIT effectively reduces tic severity in both children and adults. The Tourette Association of America recommends it, and large studies have shown it to be as effective as medication. As a type of behavioral therapy, CBIT has no serious reported side effects, making it a safe choice for managing tic disorders without medication risks.12345Why are researchers excited about this trial?
Unlike the standard treatment options for tic disorders, which often include medications like antipsychotics and alpha agonists, CBIT (Comprehensive Behavioral Intervention for Tics) offers a drug-free approach. CBIT is unique because it focuses on teaching individuals to become more aware of their tics and use competing responses to reduce them. This method empowers patients to manage their symptoms through behavior modification, potentially avoiding medication side effects. Researchers are excited about CBIT because it provides a non-invasive, empowering option that could improve quality of life for those with chronic tics.
What evidence suggests that CBIT is effective for treating chronic tics?
Research has shown that Comprehensive Behavioral Intervention for Tics (CBIT), which participants in this trial will receive, reduces the severity of tics in both children and adults. Studies have found that CBIT is more effective than supportive therapy for managing tics. In one study, 87% of participants continued to see improvements six months after finishing treatment. Reviews of multiple studies also show that CBIT is as effective as medications used for tics. While CBIT is not a cure, it helps control tics, greatly improving quality of life.678910
Who Is on the Research Team?
Christine Conelea, PhD, LP
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for young people aged 12-21 with chronic motor and/or vocal tics, which have lasted at least a year without a break of more than three months. Participants should have moderate tic severity as measured by the Yale scale, an IQ over 70, and must understand English well.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete a manualized course of 10 outpatient, weekly CBIT sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CBIT
CBIT is already approved in United States, European Union for the following indications:
- Chronic tics associated with Tourette Syndrome (TS) and Persistent Motor/Vocal Tic Disorders
- Chronic tics associated with Tourette Syndrome (TS) and Persistent Motor/Vocal Tic Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor